Scientific advisory board

Prof. Pierre-Yves Dietrich

Pierre-Yves Dietrich is director of the Centre of Oncology at the University Hospital of Geneva, Switzerland. He also heads the Laboratory of Tumor Immunology at the University of Geneva. His research is focused on brain tumor immunity and immunotherapy. He is also involved in clinical research for brain tumors, melanoma, kidney cancer and lymphoma. He is author or co-author of more than 140 per-reviewed publications.

 

 

 


Prof. Hideho Okada

Hideho Okada is a professor at the department of Neurological Surgery of the University of Pittsburgh, and co-leader of the Brain Tumor program at the University's Cancer Institute. For more than 10 years, he has focused his efforts on the development of immunotherapies for brain tumors. His work has resulted in the identification of new glioma associated antigens, enabling the launch of clinical trials with DC-based vaccines and polyIC as adjuvants.

 

 


Dr. Paul R. Walker

Paul Walker is the group leader of the laboratory of Immunobiology of Brain Tumours at the University of Geneva. He has published over 60 peer-reviewed research papers and several book chapters. His two main areas of research are T cell homing and tumor microenvironment. He serves as a referee in more than 15 peer-reviewed journals including Cancer Research, Blood and Nature Reviews Immunology.

 

 

 


Dr. Jean-Yves Bonnefoy

Jean-Yves Bonnefoy has 30 years of experience in pharmaceutical industry directing research and development projects. Presently CEO of Anagenesis Biotechnologies, he use to have managerial positions for various academic, biotechnology and pharmaceutical company accross EuropeJean-Yves holds a PhD in Immunology and is author and co-author of more than 230 publications and reviews.